Tobramycin as a pharmacologic tracer to compare airway deposition from nebulizers

Pharmacotherapy

Volumn 22, Issue 5, 2002, Pages 557-563

  Asmus, Michael J ^a,b   Stewart, Barbara A ^b,c   Milavetz, Gary ^b   Teresi, Mary E ^b   Han, Seung Ho ^b   Wang, Deli ^b   Ahrens, Richard C ^b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Healthcare Professional Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOBRAMYCIN; TOBRAMYCIN SULFATE; TRACER;

ADULT; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EXCRETION; DRUG URINE LEVEL; ELECTRONICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ABSORPTION; HUMAN; HUMAN EXPERIMENT; LUNG DEPOSIT; MALE; NEBULIZATION; NEBULIZER; NORMAL HUMAN; PRESSURE; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; SENSOR;

ADMINISTRATION, INHALATION; ADULT; ANTI-BACTERIAL AGENTS; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PROSPECTIVE STUDIES; TOBRAMYCIN;

EID: 0036239180     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.8.557.33202     Document Type: Article

References (38)

1. In vivo evaluation of the new multiple dose powder inhaler and the Rotahaler using the gamma scintigraphy
2. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction
3. Pulmonary deposition of salbutamol aerosol delivered by metered-dose inhaler, jet nebulizer, and ultrasonic nebulizer in mechanically ventilated rabbits
4. Inhalation therapy in asthma: Nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children
5. Scintigraphic assessment of therapeutic aerosols
6. In vivo evaluation of dosage forms: Application of gamma scintigraphy to non-enteral routes of administration
7. Methods to determine lung distribution of inhaled drugs: Could gamma scintigraphy be the gold standard?
8. Qualitative deposition of aerosolized gentamicin in cystic fibrosis
9. Lung distribution and pharmacokinetics of aerosolized tobramycin
10. Standards for bioequivalence of inhaled products
11. Nebulizer performance: AFLM study - Association Francaise de lutte contre la mucoviscidose
12. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols
13. Effect of dead volume on the efficiency and the cost to deliver medications in cystic fibrosis with four disposable nebulizers
14. Inhalation of tobramycin in cystic fibrosis. I. The choice of a nebulizer
15. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma
16. Kanamycin
17. Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis
18. Comparative pharmacokinetics of amikacin and kanamycin
19. Pharmacokinetics of gentamicin: Distribution and plasma and renal clearance
20. A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis
21. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa
22. Long-term tobramycin aerosol therapy in cystic fibrosis
23. Efficacy of aerosolized tobramycin in patients with cystic fibrosis
24. Some suggestions for measuring predictive performance
25. Bioavailability
26. Designs of bioavailability studies
27. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion
28. Delivery of aerosolized medications to intubated babies
29. Crying significantly reduces absorption of aerosolized drug in infants
30. Determination of the relative bioavailability of nedocromil sodium to the lung following inhalation using urinary excretion
31. Determination of the relative bioavailability of salbutamol to the lung following inhalation
32. Volumatic usage: Some generic salbutamol metered-dose inhalers can be used
33. Relative bioavailability of salbutamol to the lung following inhalation via a novel dry-powder inhaler and a standard metered-dose inhaler
34. Determination of salbutamol enantiomers in human plasma and urine by chiral high-performance liquid chromatography
35. Determination of disodium cromoglycate in human urine by high-performance liquid chromatography with post-column photoirradiation-fluorescence detection
36. Validation of a high-performance liquid chromatography assay for urinary nedocromil sodium following oral and inhaled administration